Episurf Medical announced that the company has been informed by its notified body that the review process for obtaining CE mark for the ankle implant Episealer® Talus has been concluded and that the final formal process for issuing the CE-certificate is expected to be completed within 2 weeks. The implant is intended for osteochondral lesions of the talar dome of the ankle joint. The new ankle implant is supplied together with a kit of surgical tools, and the devices are based on the same technology platform as the company's Episealer® knee devices, with an individualised design based on medical imaging and 3D modulation. In connection with this, the company has a parallel process to receive CE mark for an individualised osteotomy guide that is intended to help surgeons to find the correct position and depth of the sawing when performing a medial malleolar osteotomy.